ERBB2 and neoplasm: For the HER2 gene, there was a trend towards association of HER2 gene expression alterations with the tumour location in the rectum if any of the three criteria was used (P = 0.011, P = 0.073, and P = 0.010 for the amplification status, GCN gain and ASCO/CAP criterion, respectively).